Drug profile · INN
sacituzumab govitecan-hziy
TRODELVY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sacituzumab govitecan-hziy (TRODELVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN sacituzumab govitecan-hziy
Brand TRODELVY
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is sacituzumab govitecan-hziy?
sacituzumab govitecan-hziy (TRODELVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sacituzumab govitecan-hziy?
TRODELVY is a marketed brand name for sacituzumab govitecan-hziy. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sacituzumab govitecan-hziy?
sacituzumab govitecan-hziy has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.